PathScience, Inc. Information

PathScience develops AI-enabled digital staining technology for digital pathology workflows. The company’s Direct-to-Digital Staining approach uses imaging and machine learning techniques to generate H&E-style virtual stain images from unstained tissue scans. PathScience is focused on moving digital pathology upstream, closer to the point where pathology images are created, not just where they are viewed, managed, or analyzed. PathScience’s work sits within the emerging virtual staining and computational pathology segment of digital pathology. The company is initially focused on dermatopathology and Mohs surgery workflows, where speed, tissue preservation, visual consistency, and pathologist-centered review are especially important. The goal of PathScience’s technology is to support familiar, interpretable pathology images while reducing reliance on traditional chemical staining steps and preserving tissue for additional analysis. The company’s platform is designed to fit into existing digital pathology and scanner workflows. PathScience maintains a patent portfolio related to virtual staining and digital pathology imaging, including issued U.S. patents covering devices, systems, and methods for virtual staining. PathScience is building the upstream layer of digital pathology: Direct-to-Digital Staining for modern pathology workflows.